Clinical trials
Phase 1 Congenital Abnormalities trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
104 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 3 |
| 2002 | 7 |
| 2003 | 9 |
| 2004 | 15 |
| 2005 | 14 |
| 2006 | 6 |
| 2007 | 6 |
| 2008 | 6 |
| 2009 | 4 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 5 |
| 2013 | 6 |
| 2014 | 3 |
| 2015 | 5 |
| 2017 | 1 |
| 2018 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 79 |
| Terminated | 22 |
| Recruiting | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 27 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 8 |
| Fred Hutchinson Cancer Center | 6 |
| Masonic Cancer Center, University of Minnesota | 4 |
| Roswell Park Cancer Institute | 4 |
| Case Comprehensive Cancer Center | 3 |
| City of Hope Medical Center | 3 |
| University of Medicine and Dentistry of New Jersey | 3 |
| Vion Pharmaceuticals | 3 |
| Alison Walker | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Congenital Abnormalities | 104 |
| Leukemia, Myeloid, Acute | 87 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 58 |
| Leukemia | 43 |
| Blast Crisis | 36 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 35 |
| Leukemia, Erythroblastic, Acute | 33 |
| Leukemia, Megakaryoblastic, Acute | 32 |
| Leukemia, Monocytic, Acute | 32 |
| Leukemia, Myelomonocytic, Acute | 31 |
Trials
Showing 1 to 25 of 104. Each trial links to its page on Pharma Observatory.
4 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.